BridgeBio Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO

Neil Kumar

CEONeil Kumar

Employees

730

Employees730

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2015

Founded2015

Employees

730

Employees730

BBIO Key Statistics

Market cap

6.41B

Market cap6.41B

Price-Earnings ratio

-9.56

Price-Earnings ratio-9.56

Dividend yield

—

Dividend yield—

Average volume

3.56M

Average volume3.56M

High today

$34.01

High today$34.01

Low today

$33.24

Low today$33.24

Open price

$33.66

Open price$33.66

Volume

2.20M

Volume2.20M

52 Week high

$39.54

52 Week high$39.54

52 Week low

$21.62

52 Week low$21.62

BBIO News

TipRanks 1d

Major Shareholder Sells Millions in BridgeBio Pharma Stock!

New insider activity at BridgeBio Pharma ( (BBIO) ) has taken place on May 15, 2025. Confident Investing Starts Here: Quickly and easily unpack a company's pe...

Analyst ratings

84%

of 19 ratings

Buy

84.2%

Hold

15.8%

Sell

People also own

Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.